Apixaban and rivaroxaban are the oral anticoagulants most frequently used to treat acute venous thromboembolism. However, uncertainty remains about the difference in bleeding risk between the two ...

“I’ve spent a long time exploring the crystalline beauty of traditional mathematics, but now I’m feeling an urge to study something slightly more earthy,” John Baez wrote on his blog in 2011. An ...

In 1942, when Jackson Pollock was still an emerging artist, he displayed some of his work at a group exhibition in New York City. One of the other painters in the show, fellow Abstract Expressionist ...

The Muscarelle Museum of Art takes an engaging, expansive approach to highlighting the often-overlooked female practitioners of the assertive midcentury style. Karen Wilkin ...

In 2024, art collector Christian Levett opened Europe’s first museum dedicated to women artists in a little town in the south of France. But for those of us who can’t make the trip to the Femmes ...

The Python extension now supports multi-project workspaces, where each Python project within a workspace gets its own test tree and Python environment. This document explains how multi-project testing ...

PyPy, an alternative runtime for Python, uses a specially created JIT compiler to yield potentially massive speedups over CPython, the conventional Python runtime. But PyPy’s exemplary performance has ...

Understand the difference between Data Types and Abstract Data Types (ADT) in this clear breakdown of data structure fundamentals. Learn how they are defined, how they work, and why ADTs are essential ...

Is Mojo still a contender for Python’s data science crown? AI and machine learning outside of Python There’s no question Python is the default choice for machine learning and data science. That ...

What’s the best way to bring your AI agent ideas to life: a sleek, no-code platform or the raw power of a programming language? It’s a question that sparks debate among developers, entrepreneurs, and ...

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...